HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation

被引:122
作者
Oseroff, C
Kos, F
Bui, HH
Peters, B
Pasquetto, V
Glenn, J
Palmore, T
Sidney, J
Tscharke, DC
Bennink, JR
Southwood, S
Grey, HM
Yewdell, JW
Sette, A
机构
[1] La Jolla Inst Allergy & Immunol, San Diego, CA 92109 USA
[2] Epimmune, San Diego, CA 92121 USA
[3] NIH, Viral Dis Lab, Bethesda, MD 20892 USA
[4] Queensland Inst Med Res, Div Infect Dis & Immunol, Brisbane, Qld 4029, Australia
关键词
immunodominance; smallpox vaccination; virulence factors;
D O I
10.1073/pnas.0506768102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We have analyzed by ex vivo ELISPOT the anti-vaccinia cytotoxic T lymphocyte responses of peripheral blood mononuclear cells from humans vaccinated with Dryvax vaccine. More than 6,000 pepticles from 258 putative vaccinia ORFs predicted to bind the common molecules of the HLA A1, A2, A3, A24, B7, and B44 supertypes were screened with peripheral blood mononuclear cells of 31 vaccinees. A total of 48 epitopes derived from 35 different vaccinia antigens were identified, some of which (B8R, D1R, D5R, C101L, C19L, C7L, F12, and O1L) were recognized by multiple donors and contain multiple epitopes recognized in the context of different HLA types. The antigens recognized tend to be >100 residues in length and are expressed predominantly in the early phases of infection, although some late antigens were also recognized. Viral genome regulation and virulence factor were recognized most frequently, whereas few structural proteins were immunogenic. Finally, most epitopes were highly conserved among vaccinia virus Western Reserve, variola major and modified vaccinia Ankara, supporting their potential use in vaccine and diagnostic applications.
引用
收藏
页码:13980 / 13985
页数:6
相关论文
共 33 条
  • [1] Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses
    Belyakov, IM
    Earl, P
    Dzutsev, A
    Kuznetsov, VA
    Lemon, M
    Wyatt, LS
    Snyder, JT
    Ahlers, JD
    Franchini, G
    Moss, B
    Berzofsky, JA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) : 9458 - 9463
  • [2] VACCINIA VIRUS SERPINS B13R AND B22R DO NOT INHIBIT ANTIGEN PRESENTATION TO CLASS I-RESTRICTED CYTOTOXIC T-LYMPHOCYTES
    BLAKE, NW
    KETTLE, S
    LAW, KM
    GOULD, K
    BASTIN, J
    TOWNSEND, ARM
    SMITH, GL
    [J]. JOURNAL OF GENERAL VIROLOGY, 1995, 76 : 2393 - 2398
  • [3] Targeting antigen in mature dendritic cells for simultaneous stimulation of CD4+ and CD8+ T cells
    Bonini, C
    Lee, SP
    Riddell, SR
    Greenberg, PD
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (08) : 5250 - 5257
  • [4] Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine
    Bronte, V
    Carroll, MW
    Goletz, TJ
    Wang, M
    Overwijk, WW
    Marincola, F
    Rosenberg, SA
    Moss, B
    Restifo, NP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 3183 - 3188
  • [5] TEMPORAL REGULATION OF INFLUENZA HEMAGGLUTININ EXPRESSION IN VACCINIA VIRUS RECOMBINANTS AND EFFECTS ON THE IMMUNE-RESPONSE
    COUPAR, BEH
    ANDREW, ME
    BOTH, GW
    BOYLE, DB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (12) : 1479 - 1487
  • [6] A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
    Currier, JR
    Kuta, EG
    Turk, E
    Earhart, LB
    Loomis-Price, L
    Janetzki, S
    Ferrari, G
    Birx, DL
    Cox, JH
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) : 157 - 172
  • [7] Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination:: A phase I trial in metastatic melanoma
    Di Nicola, M
    Carlo-Stella, C
    Mortarini, R
    Baldassari, P
    Guidetti, A
    Gallino, GF
    Del Vecchio, M
    Ravagnani, F
    Magni, M
    Chaplin, P
    Cascinelli, N
    Parmiani, G
    Gianni, AM
    Anichini, A
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (16) : 5381 - 5390
  • [8] Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data
    Doolan, DL
    Southwood, S
    Freilich, DA
    Sidney, J
    Graber, NL
    Shatney, L
    Bebris, L
    Florens, L
    Dobano, C
    Witney, AA
    Appella, E
    Hoffman, SL
    Yates, JR
    Carucci, DJ
    Sette, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (17) : 9952 - 9957
  • [9] Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines
    Drexler, I
    Staib, C
    Kastenmüller, W
    Stevanovic, S
    Schmidt, B
    Lemonnier, FA
    Rammensee, HG
    Busch, DH
    Bernhard, H
    Erfle, V
    Sutter, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (01) : 217 - 222
  • [10] ESPOSITO JJ, 2001, FIELDS VIROLOGY, P2885